DOLIO SABIN ONE AND THREE (ORAL)
POLIOMYELITIS VIRUS TYPES 1,3 (LIVE, INACTIVATED; ORAL)
What it does
Poliomyelitis is a viral disease that can cause paralysis. Vaccination is key to prevention.
Commonly used for: poliomyelitis (polio)
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Medicines Control Authority of Zimbabwe · fetched 2026-04-18 08:22:06 · updated 2026-09-20 04:30:05
About poliomyelitis
Poliomyelitis is a viral disease that can cause paralysis. Vaccination is key to prevention.
What it treats
- poliomyelitis (polio)
How it works
Vaccines stimulate the immune system to recognize and fight the poliovirus, preventing infection.
Who it's for
The vaccine is recommended for children and individuals at risk of exposure to the virus.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About types
Types are a group of medicines used to treat various conditions.
How it works
Types work in different ways depending on their specific function.
Who it's for
Types may be prescribed for individuals with specific health issues.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About virus
Viruses are microscopic organisms that can cause infections in humans, animals, and plants.
What it treats
- viral infections
- common cold
- influenza (flu)
- HIV/AIDS
- hepatitis
How it works
Viruses invade living cells and use them to reproduce, which can lead to illness.
Who it's for
Viruses can affect anyone, but some groups, like those with weakened immune systems, are more at risk.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: poliomyelitis
Poliomyelitis, commonly known as polio, is an infectious disease caused by the poliovirus. It primarily affects children under five years of age and can lead to paralysis, respiratory issues, and in severe cases, death. The virus is transmitted through the fecal-oral route or, less commonly, through contaminated water or food. Vaccination has significantly reduced the incidence of polio worldwide. The disease can manifest in various forms, including asymptomatic, non-paralytic, and paralytic poliomyelitis.
Indications
- Prevention of poliomyelitis infection
- Vaccination in children and high-risk populations
Dosage
Children: Refer to the BNF for Children for specific dosages and recommendations for vaccination schedules.
Adults: Refer to specific vaccination guidelines for adults, as dosages may vary based on risk factors and prior vaccination history.
Mechanism of action
Poliovirus enters the body through the oral route, replicating in the oropharynx and gastrointestinal tract before spreading to the central nervous system via the bloodstream. Once inside the CNS, the virus selectively infects motor neurons in the anterior horn of the spinal cord, leading to cell lysis and resulting in muscle weakness or paralysis. The immune response to the virus contributes to inflammation and further neuronal damage.
Pharmacodynamics
The poliovirus's pathogenicity is primarily due to its ability to evade the host's immune response and its selective neurotropism. The destruction of motor neurons leads to flaccid paralysis, with recovery possible in some cases as the motor neurons may regenerate. The severity of the disease correlates with the extent of neuronal involvement, which can vary widely among individuals.
Pharmacokinetics
Poliovirus is an RNA virus that does not undergo traditional pharmacokinetic processes as it is not treated with drugs. Instead, the prevention of polio relies on vaccination strategies. The inactivated poliovirus vaccine (IPV) and the oral poliovirus vaccine (OPV) are used to induce immunity. After administration, the vaccines promote the development of antibodies against the virus without causing disease.
Contra-indications
- Hypersensitivity to the vaccine component
- Severe immunodeficiency
- Acute febrile illness
Adverse effects
- Pain at injection site
- Fever
- Fatigue
- Headache
- Nausea
- Allergic reactions
Interactions
- Immunosuppressive therapies may reduce vaccine efficacy
- Concomitant administration with other vaccines may affect immune response
Precautions
- Use with caution in individuals with moderate to severe acute illness
- Consider history of allergic reactions
- Monitor for signs of anaphylaxis after administration
Pregnancy
Poliomyelitis vaccination is generally considered safe during pregnancy, but consult a healthcare professional.
Breast-feeding
The vaccine is considered safe for breastfeeding mothers.
Storage
Store at 2 to 8 degrees Celsius. Do not freeze. Protect from light.
Formulations
- Inactivated poliovirus vaccine (IPV)
- Oral poliovirus vaccine (OPV)
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: types
Types are a class of medications that are used in various therapeutic applications. They often refer to specific subclasses of drugs that are categorized based on their chemical structure, mechanism of action, or therapeutic effects. Types can include, but are not limited to, analgesics, antibiotics, antihypertensives, and many others, each serving distinct clinical purposes.
Dosage
Children: Refer to specific drug information for paediatric dosing guidance.
Adults: Refer to specific drug information for dosing guidance.
Mechanism of action
The mechanism of action for drugs classified under types varies widely depending on the specific drug. Generally, they may function by inhibiting specific enzymes, blocking receptors, or modulating biological pathways to achieve their therapeutic effects.
Pharmacodynamics
Pharmacodynamics for types of drugs varies significantly depending on the specific medication. In general, pharmacodynamics describes the relationship between drug concentration and effect, including the drug's efficacy, potency, and duration of action. Common dynamics include receptor binding, post-receptor effects, and the drug's influence on physiological functions.
Pharmacokinetics
Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of drugs within the body. For various types of drugs, absorption may occur via oral, intravenous, or other routes, distribution is influenced by protein binding and tissue permeability, metabolism typically occurs in the liver, and excretion occurs primarily via renal pathways. Specific parameters such as half-life, bioavailability, and clearance rates depend on the particular drug type.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: virus
Viruses are submicroscopic infectious agents that replicate only inside the living cells of an organism. They are composed of genetic material (either DNA or RNA) surrounded by a protein coat and, in some cases, an outer lipid envelope. Viruses can infect all types of life forms, from animals and plants to microorganisms, including bacteria (bacteriophages). They are responsible for a wide range of diseases, from the common cold to serious conditions such as HIV/AIDS, influenza, and COVID-19.
Indications
- Influenza
- HIV/AIDS
- Hepatitis B and C
- Herpes simplex virus infections
- Cytomegalovirus infections
- COVID-19
- Respiratory syncytial virus infections
Dosage
Children: Refer to specific antiviral agents for dosing guidance.
Adults: Refer to specific antiviral agents for dosing guidance.
Mechanism of action
Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.
Pharmacodynamics
The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.
Pharmacokinetics
Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- ABRYSVO · Pfizer
- AVI IBD PLUS · Laprovet
- AVI ND HB1 · Laprovet
- AVI ND HBI+IB LIVE FREEZE-DRIED VACCINE (NEWCASTLE DISEASE VIRUS, HITCHNE BI STRAIN AT LEAST 10^5.5 EID50 + AVIAN INFECTIONS BRONCHITIS VIRUS, MASSACHUSETTS TYPE B-48 STRAIN AT LEAST 10^3.0 EID50) · Laprovet
- AVI ND LASOTA · Laprovet Hungary
- BIOCAN DHPPi+LR · Bioveta
- ABRYSVO · Pfizer
- ADACEL POLIO {DIPHTHERIA TETANUS PERTUSSIS ACELLULAR COMPONENT) AND POLIOMYELITIS (INACTIVATED VACCINE (ADSORBED REDUCED ANTIGENS)} · Ressourcethica
- AVAXIM 160 U INACTIVATED ADOSORBED HEPATITIS A VACCINE · Ressourcethica
- AVAXIM 80 U PEDIATRIC INACTIVATED ADOSORBED HEPATITIS A VACCINE · Ressourcethica